Glucosylceramide synthetase inhibitor, d-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol exhibits a novel decarcinogenic activity against Shope carcinoma cells
- 19 March 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 101 (1) , 25-30
- https://doi.org/10.1016/0304-3835(95)04106-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Monoclonal antibody E6G6 recognizes glycolipids as a differentiation antigen in Shope carcinoma cellsCancer Letters, 1994
- Aberrant expression of blood group H-antigen in Shope carcinoma cellsCancer Letters, 1992
- Establishment from Shope Carcinoma Induced in an Inbred Rabbit of Culture Cell Lines with Various Potentials for Differentiation and TumorigenicityJournal of Investigative Dermatology, 1991
- Effects of an Inhibitor of Glucosylceramide Synthase on Glycosphingolipid Synthesis and Neurite Outgrowth in Murine Neuroblastoma Cell Lines1The Journal of Biochemistry, 1991
- Expression of Blood-Group Antigen A — A Favorable Prognostic Factor in Non-Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate AntigensAdvances in Cancer Research, 1989
- Antitumor activity via inhibition of glycosphingolipid biosynthesisCancer Letters, 1987
- Efficient detection of soft agar grown colonies using a tetrazolium saltCancer Letters, 1975